期刊文献+

钙化心肌细胞肾上腺髓质素和受体活性修饰蛋白2mRNA含量的变化 被引量:4

Changes of Amount of Adrneomedullin mRNA and Receptor Activity Modifying Protein 2 mRNA in Calcified Myocardial Cells
下载PDF
导出
摘要 为探讨离体钙化处理的新生大鼠心肌细胞肾上腺髓质素及受体活性修饰蛋白 2mRNA含量的改变及意义。采用β 磷酸甘油制备钙化的心肌细胞 ;放射免疫分析方法测定心肌细胞中肾上腺含量 ;竞争性定量逆转录—多聚酶链反应测定心肌细胞肾上腺髓质素和受体活性修饰蛋白 2mRNA水平。结果显示 ,钙化心肌细胞钙含量较非钙化心肌细胞高 3倍 (P <0 .0 1) ,肾上腺髓质素含量较非钙化心肌细胞高 136 .9% (P <0 .0 1) ,钙化心肌细胞肾上腺髓质素和受体活性修饰蛋白 2mRNA含量分别增加 2 4 % (P <0 .0 5 )和 2 5 % (P <0 .0 5 )。而且钙化心肌细胞受体活性修饰蛋白 2和肾上腺髓质素基因表达上调的程度相平行。钙化心肌细胞肾上腺髓质素生成增加 ,肾上腺髓质素和受体活性修饰蛋白 2mRNA表达亦明显上调 ,提示肾上腺髓质素 受体活性修饰蛋白 2信号途径在心肌细胞钙化发展中可能具有一定的调节作用。 Aim To explore the changes and significance of adrenomedullin(ADM) mRNA and receptor activity modifying protein 2(RAMP2) mRNA in calcified myocardial cells. Methods Calcified myocardial cells was prepared with β glycerophosphate. Content of ADM in VSMC was measured by radioimmunoassay(RIA). The amount of ADM mRNA and RMAP2 mRNA was determined by competitive RT PCR. Results The content of calcium and ADM in calcified myocardial cells was increased by 138% and 136.9%(all P<0.01), respectively, compared with control. The amount of ADM mRNA and RMAP2 mRNA in calcified myocardial cells was elevated by 24% and 25%( all P<0.05), respectively, compared with control. The elevated level of RAMP2 mRNA was parallel to that of ADM mRNA in calcified myocardial cells. Conclusions Content of ADM was increased, and gene expression of ADM and RAMP2 was up regulated in calcified myocardial cells, which suggested that ADM/RAMP2 may have important regulator role in process of calcification of myocardidal cells.
出处 《中国动脉硬化杂志》 CAS CSCD 2002年第5期375-378,共4页 Chinese Journal of Arteriosclerosis
基金 国家重大基础研究发展规划项目 (G2 0 0 0 0 5 690 5 )资助
关键词 心肌细胞 钙化 肾上腺髓质素 受体活性修饰蛋白2 MRNA Myocardial Cells, Calcified Adrenomedullin Receptor Activit Modifying Protein 2 mRNA
  • 相关文献

参考文献2

二级参考文献12

  • 1[1]Martinez A, Kapas S, Miller MJ, et al. Coexpression of receptors for adrenomedullin,calcitonin gene-related peptide,and amylin in pancreatic beta cells. Endocrinology, 2000, 141∶406~411.
  • 2[2]Wimalawansa SJ. Amylin,calcitonin gene-related peptide,calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol, 1997,11∶167~239.
  • 3[3]Mclatchie LM, Fraser NJ, Main MJ, et al.RAMPs regulate the transport and ligand specifity of the calcitonin -receptor-like receptor. Nature, 1998,393∶333~339.
  • 4[4]Frayon S, Cueille C,Gnidehou S, et al. Dexamethasone increases RAMP1 and CRLR mRNA expression in human vascular smooth muscle cells. Biochem Biophys Res Commun, 2000,270∶1063~1067.
  • 5[5]Nagac T, Mukoyama M, Sugawara A, et al. Rat receptor-activity-modifying protein(RAMPs) for adrenomedullin/CGRP receptor: cloning and regulation in obstructive nephropathy. Biochem Biophys Res Commun, 2000,270∶89~93.
  • 6[6]Foord SM,Marshall FH. RAMPs: accessory proteins for seven transmembrane domain receptors.Trends Pharmacol Sci, 1999,20∶184~187.
  • 7[7]Christopoulos G, Peery KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol, 1999,56∶235~242.
  • 8[8]Frash NJ, Wise A, Brown J, et al. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Parmacol, 1999,55∶1054~1059.
  • 9[9]Zumpe ET, Tilakaratne N, Fraser NJ, et al. Multiple ramp domain are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Biochem Biophys Res Commun, 2000,267:368~372.
  • 10[10]Oie E, Vinge LE, Yndestad A, et al. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation, 2000, 101∶415~422.

共引文献18

同被引文献44

  • 1杨军,赵东,常英姿,田青,赵云涛,石湘云,张肇康,唐朝枢.肾上腺髓质素对大鼠异丙肾上腺素心肌坏死的保护作用[J].中国药理学通报,1996,12(6):530-533. 被引量:8
  • 2Iribarren C, Sidney S, Sternfeld B, Browner WS.Calcification of the aortic arch:risk factor and association with coronary heart disease, stroke, and peripheral vascular disease.JAMA, 2000, 88:26-33
  • 3Christian RC, Fitzpatrick LA.Vascular calcification.Curr Opin Nephrol Hypertens, 1999, 8 (4):443-448
  • 4Farzaneh-Far A, Proudfoot D, Shanahan C, Weissberg PL.Vascular and valvar calcification:recent advances.Heart, 2001, 85:13-17
  • 5Hinson JP, Kapas S, Smith DM.Adrenomedullin, a multifunctional regulatory peptide.Endocrine review, 2000, 21:138-167
  • 6Zhang B, Tang C, Jiang Z, Qi Y, Pang Y, Du J, et al.Effects of adrenomedullin on vascular calcification in rats.Zeitschrift Fur Kardiologie, Band 91,Heft 7 2002.
  • 7Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi H, Morii H, et al.β-Glycerophosphate accelerates calcification in cultured bovine smooth muscle cells.Arterioscler Thromb Vasc Biol, 1995, 15:2 003-009
  • 8Campbell JH, Campbell GR.Culture techniques and their applications to studies of vascular smooth muscle.Clin Sci, 1993, 85:501-512
  • 9Qi YF, BU DF, Niu DD, Shi YR, Wang SH, Pang YZ, et al.Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene.Peptides, 2002, 23:1 141-147
  • 10Proudfoot D, Shanahan CM, Weissberg PL.Vascular calcification:new insights into an old problem.J Pathol, 1998, 185:1-3

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部